Minerva Neurosciences, Inc. (NERV) Financials

NERV Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 95.1 billion 296.6 billion
March 31, 2026 94.0 million 348.0 million
Dec. 31, 2025 98.0 million 238.7 million
Sept. 30, 2025 28.1 million 62.7 million

NERV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -13.3 billion 2.3 billion
March 31, 2026 -5.4 billion 8.7 billion
Dec. 31, 2025 -4.5 million 459028
Sept. 30, 2025 -2.9 million 272897

NERV Net Income

No data available :(

NERV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 75.3 billion 71.7 million -
March 31, 2026 78.2 million 65.0 million -
Dec. 31, 2025 82.3 million - -
Sept. 30, 2025 12.3 million - -

NERV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 79.1 million
March 31, 2026 43.9 million
Dec. 31, 2025 11.1 million
Sept. 30, 2025 7.6 million

NERV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 7.2 million 3.5 million -
March 31, 2026 - 5.3 billion 11.4 billion -
Dec. 31, 2025 - 2.2 million 2.8 million -
Sept. 30, 2025 2 925377 1.9 million -

NERV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - 1360
Sept. 30, 2025 - 1361

NERV

Price: $4.44

52 week price:
1.76
12.46

Earnings Per Share: -40.15 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 48300

Ebitda: -11.1 million

Market Capitalization: 220.6 million

Links: